A study conducted in San Antonio on Jan 28, 2026, found that a combination of THC, the main psychoactive component in cannabis, and celecoxib, a drug commonly used for its anti-inflammatory properties, demonstrated enhanced cognitive functions. This research showcases the increasing understanding of the potential medical advantages of THC, with a focus on its neuroprotective abilities. The study's results highlight the significant impact of combining THC with celecoxib in improving cognition.